ciprofloxacin and trimethoprim, sulfadoxine drug combination

ciprofloxacin has been researched along with trimethoprim, sulfadoxine drug combination in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheong, HJ; Cho, YK; Choi, TY; Chung, MH; Kang, JO; Ki, M; Kim, J; Kim, SJ; Kim, Y; Kwon, KT; Lee, H; Lee, JS; Lim, SK; Pai, H; Park, DW; Ryu, SY; Seo, MR; Wie, SH	1
Ben-Ari, Y; Ben-Shalom, G; Ben-Shimol, S; Cavari, Y; Geffen, Y; Goldberg, L; Keller, N; Lazar, I; Nahum, E; Paret, G; Pessach, IM; Rubinstein, M; Tokatly Latzer, I	1

Other Studies

2 other study(ies) available for ciprofloxacin and trimethoprim, sulfadoxine drug combination

Article	Year
Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea. Journal of Korean medical science, 2014, Volume: 29, Issue:8 Topics: Anti-Bacterial Agents; Cefepime; Cell Survival; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Nitrofurantoin; Penicillins; Republic of Korea; Sulfadoxine; Treatment Outcome; Trimethoprim; Urinary Tract Infections	2014
Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children: A Multicenter Experience. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2019, Volume: 20, Issue:5 Topics: Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Comorbidity; Critical Illness; Drug Combinations; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Infant; Intensive Care Units, Pediatric; Male; Minocycline; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Sulfadoxine; Trimethoprim	2019

Article

Year

Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea.

Journal of Korean medical science, 2014, Volume: 29, Issue:8

Topics: Anti-Bacterial Agents; Cefepime; Cell Survival; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Nitrofurantoin; Penicillins; Republic of Korea; Sulfadoxine; Treatment Outcome; Trimethoprim; Urinary Tract Infections

2014

Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children: A Multicenter Experience.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2019, Volume: 20, Issue:5

Topics: Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Comorbidity; Critical Illness; Drug Combinations; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Infant; Intensive Care Units, Pediatric; Male; Minocycline; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Sulfadoxine; Trimethoprim

2019